On Thursday, the Centers for Disease Control and Prevention released the results of a study that reaffirmed that Pfizer's COVID-19 vaccine was safe for children aged between 5 and 11 years old.

Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot demonstrating 34.5% greater efficacy compared to a control vaccine. | Pfizer has ...

Pfizer and BioNTech said Monday that late-stage trials of its COVID-19 vaccine in children show that the shots were safe and effective in kids aged between 5 and 11. The results mark a key step ...

CLOVIS, Calif. (KFSN) -- Moms and moms-to-be trust doctors with pregnancy, with caring for their unborn child, even with getting pregnant. But data shows when it comes to the COVID-19 vaccine, there ...

Recent studies have shown that the effectiveness of Covid-19 vaccines is decreasing, though experts say the shots still work well. WSJ explains what the numbers mean and why they don’t tell the full ...

The experimental mRNA vaccine prevented 60% to 67% of flu infections, while the conventional vaccine prevented 44% to 54% of infections, said Kelly Lindert, MD, vice president of clinical research and ...

Citing a “new evidenced based philosophy,” the FDA’s Center for Biologics Evaluation and Research (CBER) is preparing to take a hard line against the common practice of administering certain ...